---
figid: PMC8137523__nihms-1662654-f0004
figtitle: Tumor suppressors act as a checkpoint for mevalonate pathway flux by suppressing
  SREBP activity
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8137523
filename: nihms-1662654-f0004.jpg
figlink: /pmc/articles/PMC8137523/figure/F4/
number: F4
caption: Tumor suppressors are in blue boxes with thick lines. Primary cilia, supported
  by VHL, Tg737, and Kif3a, are lost after transformation resulting in loss of their
  tumor suppressive function as a WNT rheostat and leading to enforced SREBP transcriptional
  activity. Wild type p53 suppresses the mevalonate by transcription of Abca1, a retrograde
  transporter of cholesterol that can suppress SREBP maturation. Certain p53 mutations
  may increase mSREBP activity through direct interaction. PTEN dampens PI3K-AKT-mTORC1
  signaling, and thus mTORC1-mediated SREBP maturation; however, co-deletion of PTEN
  and the tumor suppressor PML is required in prostate cancer to promote the lipogenic
  SREBP program.
papertitle: Targeting the Mevalonate Pathway in Cancer.
reftext: Dennis Juarez, et al. Trends Cancer. ;7(6):525-540.
year: '2021'
doi: 10.1016/j.trecan.2020.11.008
journal_title: Trends in cancer
journal_nlm_ta: Trends Cancer
publisher_name: ''
keywords: Cholesterol | Mevalonate | Statins | Prenylation | Combinations
automl_pathway: 0.9660878
figid_alias: PMC8137523__F4
figtype: Figure
redirect_from: /figures/PMC8137523__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8137523__nihms-1662654-f0004.html
  '@type': Dataset
  description: Tumor suppressors are in blue boxes with thick lines. Primary cilia,
    supported by VHL, Tg737, and Kif3a, are lost after transformation resulting in
    loss of their tumor suppressive function as a WNT rheostat and leading to enforced
    SREBP transcriptional activity. Wild type p53 suppresses the mevalonate by transcription
    of Abca1, a retrograde transporter of cholesterol that can suppress SREBP maturation.
    Certain p53 mutations may increase mSREBP activity through direct interaction.
    PTEN dampens PI3K-AKT-mTORC1 signaling, and thus mTORC1-mediated SREBP maturation;
    however, co-deletion of PTEN and the tumor suppressor PML is required in prostate
    cancer to promote the lipogenic SREBP program.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pten
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - ras
  - Ras64B
  - Ras85D
  - Crtc
  - Vhl
  - nompB
  - Klp64D
  - MKP-4
  - p38b
  - rl
  - SREBP
  - mid
  - arm
  - pan
  - p53
  - betaTub60D
  - hth
  - SCAP
  - bmm
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - KRAS
  - HRAS
  - NRAS
  - MTOR
  - RPTOR
  - VHL
  - IFT88
  - KIF3A
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PML
  - ABCA1
  - HNF4A
  - MMUT
  - TP53
  - TP63
  - TP73
  - INSIG1
  - SH2D2A
---
